Vidia Roopchand

707 total citations
7 papers, 474 citations indexed

About

Vidia Roopchand is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Vidia Roopchand has authored 7 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Virology and 2 papers in Molecular Biology. Recurrent topics in Vidia Roopchand's work include HIV Research and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (3 papers). Vidia Roopchand is often cited by papers focused on HIV Research and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (3 papers). Vidia Roopchand collaborates with scholars based in United States and Japan. Vidia Roopchand's co-authors include Maninder K. Sidhu, Barbara K. Felber, George N. Pavlakis, Shakuntala Megati, John H. Eldridge, David B. Weiner, Michael A. Egan, Margherita Rosati, Amara Luckay and Zimra R. Israel and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Vaccine.

In The Last Decade

Vidia Roopchand

7 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vidia Roopchand United States 7 328 146 126 119 98 7 474
Shakuntala Megati United States 11 331 1.0× 191 1.3× 197 1.6× 150 1.3× 172 1.8× 11 582
Mary S. Wu United States 6 307 0.9× 150 1.0× 213 1.7× 150 1.3× 149 1.5× 6 508
Mark L. Bagarazzi United States 4 296 0.9× 209 1.4× 134 1.1× 174 1.5× 90 0.9× 6 456
W P Tsai United States 9 225 0.7× 275 1.9× 118 0.9× 121 1.0× 104 1.1× 13 465
Maria Luisa Visciano United States 14 362 1.1× 349 2.4× 149 1.2× 173 1.5× 126 1.3× 25 626
Susanna Pasquini United States 11 252 0.8× 85 0.6× 106 0.8× 154 1.3× 110 1.1× 12 464
Lauren Hudacik United States 11 238 0.7× 258 1.8× 115 0.9× 109 0.9× 111 1.1× 15 432
Silke Bergmann Germany 14 190 0.6× 151 1.0× 211 1.7× 112 0.9× 153 1.6× 27 495
Michael Merva United States 9 305 0.9× 181 1.2× 136 1.1× 199 1.7× 100 1.0× 10 473
Florence Boudet France 12 277 0.8× 227 1.6× 170 1.3× 156 1.3× 162 1.7× 25 566

Countries citing papers authored by Vidia Roopchand

Since Specialization
Citations

This map shows the geographic impact of Vidia Roopchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vidia Roopchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vidia Roopchand more than expected).

Fields of papers citing papers by Vidia Roopchand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vidia Roopchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vidia Roopchand. The network helps show where Vidia Roopchand may publish in the future.

Co-authorship network of co-authors of Vidia Roopchand

This figure shows the co-authorship network connecting the top 25 collaborators of Vidia Roopchand. A scholar is included among the top collaborators of Vidia Roopchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vidia Roopchand. Vidia Roopchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Johnson, J. Erik, Lisa K. McNeil, Shakuntala Megati, et al.. (2012). Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice. Immunology Letters. 150(1-2). 134–144. 14 indexed citations
2.
Megati, Shakuntala, Vidia Roopchand, Rong Xu, et al.. (2008). Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses. Vaccine. 26(40). 5083–5094. 14 indexed citations
3.
Xu, Rong, Shakuntala Megati, Vidia Roopchand, et al.. (2008). Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines. Vaccine. 26(37). 4819–4829. 54 indexed citations
4.
Luckay, Amara, Maninder K. Sidhu, Rune Kjeken, et al.. (2007). Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques. Journal of Virology. 81(10). 5257–5269. 154 indexed citations
5.
Kutzler, Michele A., Tara M. Robinson, Michael A. Chattergoon, et al.. (2005). Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help. The Journal of Immunology. 175(1). 112–123. 152 indexed citations
6.
Schadeck, Eva B., Maninder K. Sidhu, Michael A. Egan, et al.. (2005). A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine. 24(21). 4677–4687. 61 indexed citations
7.
Egan, Michael A., Shakuntala Megati, Vidia Roopchand, et al.. (2005). Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine. 24(21). 4510–4523. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026